BNP Paribas Financial Markets’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4M | Buy |
|
|||||
|
2025
Q1 | $2.42M | Sell |
|
|||||
|
2024
Q4 | $5.11M | Buy |
|
|||||
|
2024
Q3 | $5.06M | Buy |
|
|||||
|
2024
Q2 | $2.93M | Buy |
|
|||||
|
2024
Q1 | $2.05M | Sell |
|
|||||
|
2023
Q4 | $6.41M | Buy |
|
|||||
|
2023
Q3 | $6.58M | Buy |
|
|||||
|
2023
Q2 | $7.96M | Buy |
|
|||||
|
2023
Q1 | $7.26M | Buy |
|
|||||
|
2022
Q4 | $2.82M | Sell |
|
|||||
|
2022
Q3 | $6.4M | Buy |
|
|||||
|
2022
Q2 | $2.57M | Sell |
|
|||||
|
2022
Q1 | $4.36M | Buy |
|
|||||
|
2021
Q4 | $4.37M | Buy |
|
|||||
|
2021
Q3 | $1.85M | Buy |
|
|||||
|
2021
Q2 | $393K | Sell |
|
|||||
|
2021
Q1 | $679K | Buy |
|
|||||
|
2020
Q4 | $369K | Sell |
|
|||||
|
2020
Q3 | $234K | Buy |
|
|||||
|
2020
Q2 | $131K | Sell |
|
|||||
|
2020
Q1 | $255K | Buy |
|
|||||
|
2019
Q4 | $78.4K | Sell |
|
|||||
|
2019
Q3 | $83.3K | Buy |
|
|||||
|
2019
Q2 | $73.8K | Sell |
|
|||||
|
2019
Q1 | $131K | Buy |
|
|||||
|
2018
Q4 | $10K | Sell |
|
|||||
|
2018
Q3 | $129K | Sell |
|
|||||
|
2018
Q2 | $214K | Buy |
|
|||||
|
2018
Q1 | $70.3K | Sell |
|
|||||
|
2017
Q4 | $74.7K | Buy |
|
|||||
|
2017
Q3 | $36.6K | Sell |
|
|||||
|
2017
Q2 | $23.9K | Buy |
|
|||||
|
2017
Q1 | $2.75K | Sell |
|
|||||
|
2016
Q4 | $6.66K | Sell |
|
|||||
|
2016
Q3 | $9.5K | Buy |
|
|||||
|
2016
Q2 | $5.89K | Buy |
|